Although deletion of the SMAD4 gene is associated with tumor progression, metastasis, and poor prognosis, two other studies concluded that the mutation profiles of SMAD4 are highly concordant in primary CRC and CRLM [24,30]. This evidence concerns the gene SMAD4 and colorectal carcinoma.